Amneal Spreads Bets On Generics Amid Focus On High-Barrier Opportunities
Generics Growth Supports Overall Increase In Q1 As Specialty Segment Falters
Amneal highlighted the benefits of a broad spread of generics and an increased shift towards complex products with high barriers to entry, as it reported generics sales growth in Q1 despite a tough operating environment for US generics.
